Overview
Status
Active
Registry date
2021-12-22
Share capital
5,000.00 PLN
Average employment (FTE)
5.5 (2025)
Registered address
ul. Zamknięta 10/4, 30-554 Kraków, Poland
Financials
Revenue history (in k)
Financial insight
- Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.
Filing timeliness
4 of 4 financial statements were filed late (the longest delay 65 days for 2025).
- 202518/09/2026
- 202416/07/2025
- 202318/07/2024
- 202219/07/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.27mMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD 38.87kMedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 1.17mMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 515.68kMedianUSD 173.92kAverageUSD 1.02m
Industry
Trademarks
Vamax holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| VESUNA(word) | Oct 21, 2035 |
Authorized Representatives
Agnieszka Konstanty Juszczak – Attorney-in-fact
Małgorzata Maria Konstanty – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Małgorzata Maria Konstantyage 63 | 67 | $904.92 | 67% |
Others | 33 | $445.71 | 33% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-04-01.
67 1140 2004 0000 3802 8454 9235
43 1090 0088 0000 0001 4943 2109
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Artvimed-Chrobrysp. z o.o. + limited partnership | $4,770,476.85 | artvimed.pl | ||
| Medyczne Centrum Diabetologiczno-Endokrynologiczno-Metaboliczne Diab-Endo-Metsp. z o.o. | $2,388,762.41 | diab-endo-met.pl | ||
| Paradowski Medical Groupsp. z o.o. | $2,000,181.98 | paradowskimg.pl | ||
| Ultramedsp. z o.o. | $1,554,258.78 | ultramed-krakow.pl | ||
| Centrum Medyczne Dietla 19sp. z o.o. | $1,510,970.08 | dietla19.pl | ||
| Prospersp. z o.o. | $1,079,952.09 | krakmed.pl | ||
| HSM Clinic Podgórzesp. z o.o. | $1,016,041.94 | hsm.com.pl | ||
| Zielona Karetka Clinicsp. z o.o. | $424,392.14 | zielonakaretka.pl | ||
| Mogilska-Medsp. z o.o. + limited partnership | $304,642.48 | mogilska-med.pl | ||
| Centrum Medyczne Mała Górasp. z o.o. | $276,086.74 | malagora.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-15 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2024-08-14 | Address change (Ul. Dobrego Pasterza 118c/Lu11, 31-416, Kraków → Ul. Zamknięta 10/4, 30-554, Kraków) | |
| 2024-08-14 | Name change (Vesuna → Vamax) | |
| 2021-12-22 | Entered in the register |
FAQ
The main business activity of Vamax focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on December 22, 2021.
The headquarters is located at: ul. Zamknięta 10, 30-554 Kraków.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 1,270,087, representing a decrease of 2.7% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 38,869, meaning the company decreased its profit by 60.6%.
The largest operating cost category falls under external services. This category amounted to USD 435,366 in 2025, representing 37% of all operating expenses.
Last updated: 2026-09-18